DMAAR stock

Drugs Made In America Acquisition Corp. Rights (DMAAR) 52-week high is $0.24

Drugs Made In America Acquisition Corp. Rights (DMAAR) 52-week high is $0.24. That figure is from Lician’s product cache for this name — not a placeholder and not copied across tickers.

Read the full DMAAR research page for quote, filings, and the rest of the model. This satellite exists so “Drugs Made In America Acquisition Corp. Rights 52-week high” can rank with the actual number, then send you to /stock/dmaar.

Full DMAAR analysis